Regenerative Medical Technology (RMTG) Payables (2017 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Payables of $47452.0 for Q1 2026, down 99.73% year-over-year from $17.7 million in Q1 2025, and little changed quarter-over-quarter from $47452.0 in Q4 2025.
Regenerative Medical Technology (RMTG) Payables (2017 - 2026) Analysis & Trends
Regenerative Medical Technology's Payables history runs 10 years deep, the most recent figure standing at $47452.0 for Q1 2026.
- In Q1 2026, Payables fell 99.73% year-over-year to $47452.0; the TTM figure through Mar 2026 stood at $47452.0 (down 99.73% YoY), while the FY2025 annual figure was $47452.0, down 96.28% from the prior year.
- Payables for Q1 2026 stood at $47452.0, roughly flat from $47452.0 in the prior quarter.
- The five-year high for Payables was $17.8 million in Q2 2024, with the low at $43138.0 in Q3 2025.
- The 5-year median for Payables is $2.9 million (2024), against an average of $6.1 million.
- The sharpest annual moves came in 2023 and 2026: Payables soared 2442.26% in 2023, then slumped 99.73% in 2026.
- Regenerative Medical Technology's Payables stood at $7.3 million in 2022, then slumped by 94.19% to $423480.0 in 2023, then soared by 201.39% to $1.3 million in 2024, then tumbled by 96.28% to $47452.0 in 2025, then changed by 0.0% to $47452.0 in 2026.
- Business Quant data shows RMTG's Payables at $47452.0 in Q1 2026, $47452.0 in Q4 2025, and $43138.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 35.57 Mn |
| 10 | Regenerative Medical Technology | 1.07 Mn | 8,063.99 | 1.77 Mn | 17.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 47,452.00 |
| Dec 31, 2025 | 47,452.00 |
| Sep 30, 2025 | 43,138.00 |
| Jun 30, 2025 | 17.72 Mn |
| Mar 31, 2025 | 17.72 Mn |
| Dec 31, 2024 | 1.28 Mn |
| Sep 30, 2024 | 3.49 Mn |
| Jun 30, 2024 | 17.83 Mn |
| Mar 31, 2024 | 2.94 Mn |
| Dec 31, 2023 | 423,480.00 |
| Sep 30, 2023 | 17.34 Mn |
| Jun 30, 2023 | 7.43 Mn |
| Mar 31, 2023 | 7.44 Mn |
| Dec 31, 2022 | 7.29 Mn |
| Sep 30, 2022 | 1.81 Mn |
| Jun 30, 2022 | 292,283.00 |
| Mar 31, 2022 | 450,557.00 |
| Dec 31, 2021 | 1.71 Mn |
| Sep 30, 2021 | 1.74 Mn |
| Jun 30, 2021 | 996,061.00 |